What is Zhejiang Jingxin Pharmaceutical Co., Ltd.'s (002020.SZ) StockRank?

MoatMap's StockRank for Zhejiang Jingxin Pharmaceutical Co., Ltd. (002020.SZ) is 57/100, with a Hold signal. This is a composite score combining Quality (63), Value (55), and Momentum (28) factor ranks across MoatMap's 19,000+ stock universe.

Does Zhejiang Jingxin Pharmaceutical Co., Ltd. have an economic moat?

Zhejiang Jingxin Pharmaceutical Co., Ltd. (002020.SZ) has a Quality factor score of 63/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the financial characteristics of a moated business.

Is Zhejiang Jingxin Pharmaceutical Co., Ltd. a buy, hold, or sell?

MoatMap's current signal for Zhejiang Jingxin Pharmaceutical Co., Ltd. (002020.SZ) is Hold, based on a StockRank of 57/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.

What sector is Zhejiang Jingxin Pharmaceutical Co., Ltd. in?

Zhejiang Jingxin Pharmaceutical Co., Ltd. (002020.SZ) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (China).

Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

002020.SZ

HOLDREMOVE

Zhejiang Jingxin Pharmaceutical Co., Ltd. · Healthcare · China · $1.7B · Avg Vol: $18M/d

StockRank

P/E (TTM)

13.4x

ROE

13.2%

D/E

0.0x

Dividend %

2.8%

Director Trades · 180d

None in 180d →

Buybacks · 180d

$90M · 1d →

AI CONVICTION THESIS

Zhejiang Jingxin Pharmaceutical is a domestic Chinese pharmaceutical firm. It lacks the global scale, validation, and pricing power of the high-end CDMOs targeted by our CDMO Pricing Power Cycle theme.

COMPANY DESCRIPTION

Zhejiang Jingxin Pharmaceutical Co., Ltd. manufactures chemical APIs and finished dosages, focusing on cardiovascular, digestive, and central nervous system (CNS) therapies. The company is a leading domestic manufacturer of CNS drugs, supported by a highly cost-competitive, vertically integrated supply chain. It is a specialty pharmaceutical player leveraging strong R&D to drive generic drug substitution.

FINANCIAL SUMMARY

Year	2022	2023	2024	2025	CAGR
Revenue	559M	591M	615M	601M	2.5%
EPS	0.11	0.11	0.12	0.14	6.1%
Shares	861M	861M	861M	861M	0.0%
Debt	44M	48M	47M	46M	1.9%
Equity	761M	815M	882M	862M	4.3%
Op CF	126M	117M	107M	115M	-3.0%
Inv CF	-109M	-109M	-213M	54M	—
Fin CF	-28M	-36M	-41M	-135M	—

PRICE (1M)-18.2%

SMA 50SMA 200

$1.80

RSI (14)

32.1

52W High

$3.25

From 52W High

0.6%

SCORE BREAKDOWN

Quality

ROIC

14.0%83.1

ROE

13.2%79.2

GP/Assets

25.0%56.7

Op. Margin

20.6%83.3

FCF/Assets

—N/A

Piotroski

—55.8

Int. Cover

50.0x91.4

D/E Ratio

0.03x80.2

Current Ratio

—N/A

Value

P/E (TTM)

13.4x78.2

EV/EBITDA

8.9x45.4

P/FCF

—N/A

P/B

1.7x62.0

P/S

2.6x60.4

Div Yield

2.8%66.4

Momentum

52W High %

55%31.4

RS 6M

-42%27.3

SMA 50/200

0.83x17.1

EPS Rev 4W

—N/A

EPS Rev 12W

—N/A

EPS Improve

+2%22.0

Q Growth

1%41.8

FUNDAMENTALS

Market Cap

$1.7B

P/E (Forward)

13.1x

Gross Margin

50.1%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 002020.SZ are excluded.

Ticker	Company	Mkt Cap	StockRank	Signal
002020.SZ	Zhejiang Jingxin Pharmaceutical Co., Ltd.(you)	$1.7B	57	HOLD
603456.SS	Zhejiang Jiuzhou Pharmaceutical Co., Ltd	$1.7B	62	HOLD
603538.SS	Ningbo Menovo Pharmaceutical Co., Ltd.	$1.6B	51	HOLD
000756.SZ	Shandong Xinhua Pharmaceutical Company Limited	$1.4B	62	HOLD
601089.SS	Beijing Foyou Pharma CO.,LTD	$1.3B	61	HOLD
300725.SZ	PharmaBlock Sciences (Nanjing), Inc.	$1.2B	60	HOLD
300119.SZ	Tianjin Ringpu Bio-Technology Co.,Ltd.	$1.1B	55	HOLD
300601.SZ	Shenzhen Kangtai Biological Products Co., Ltd.	$2.1B	51	HOLD
603707.SS	Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd.	$1.9B	65	BUY
301246.SZ	Hubei Hongyuan Pharmaceutical Technology Co., Ltd.	$1.9B	66	BUY

Peer medians: ROE 4.7% · P/E 27.9x · Gross margin 53.1%

Zhejiang Jingxin Pharmaceutical Co., Ltd. (002020.SZ) — Stock Score Summary

Zhejiang Jingxin Pharmaceutical Co., Ltd. (002020.SZ) has a MoatMap StockRank of 57/100 based on Quality (63/100), Value (55/100), and Momentum (28/100) factor scores. The current signal is HOLD. Zhejiang Jingxin Pharmaceutical is a domestic Chinese pharmaceutical firm. It lacks the global scale, validation, and pricing power of the high-end CDMOs targeted by our CDMO Pricing Power Cycle theme.

Key Financial Metrics

Price	$1.80
Market Cap	$1.7B
P/E (TTM)	13.43
P/E (Forward)	13.15
Price/Book	1.68
Return on Equity	13.2%
Return on Invested Capital	14.0%
Debt/Equity	2.60
Gross Margin	50.1%
Operating Margin	20.6%
Revenue Growth	-3.5%
Dividend Yield	2.8%

Zhejiang Jingxin Pharmaceutical Co., Ltd. operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector (China).

Frequently Asked Questions

What is Zhejiang Jingxin Pharmaceutical Co., Ltd.’s (002020.SZ) StockRank?: MoatMap’s StockRank for Zhejiang Jingxin Pharmaceutical Co., Ltd. (002020.SZ) is 57/100, with a Hold signal. It is a composite of Quality (63), Value (55), and Momentum (28) factor ranks across MoatMap’s 19,000+ stock universe.
Does Zhejiang Jingxin Pharmaceutical Co., Ltd. have an economic moat?: Zhejiang Jingxin Pharmaceutical Co., Ltd. (002020.SZ) has a Quality factor score of 63/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Zhejiang Jingxin Pharmaceutical Co., Ltd. a buy, hold, or sell?: MoatMap’s current signal for Zhejiang Jingxin Pharmaceutical Co., Ltd. (002020.SZ) is Hold, based on a StockRank of 57/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Zhejiang Jingxin Pharmaceutical Co., Ltd. in?: Zhejiang Jingxin Pharmaceutical Co., Ltd. (002020.SZ) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (China).